Mechanisms of trastuzumab resistance and their clinical implications

被引：60
|
作者：
Lan, KH
Lu, CH
Yu, DH
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA
来源：
TUMOR PROGRESSION AND THERAPEUTIC RESISTANCE | 2005年 / 1059卷
关键词：
trastuzumab; resistance; ErbB2; breast cancer; PI3K; PTEN;
D O I：
10.1196/annals.1339.026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Trastuzumab (Herceptin"') is an excellent model of rationally designed targeted cancer treatment. However, less than 35% of patients with ErbB2-positive breast tumors respond to trastuzumab as a single agent, and 2-5% of trastuzumab-treated patients suffer from severe side effects, including cardiac dysfunction. Recent progress in understanding the mechanisms of trastuzumab antitumor function and cellular defects leading to trastuzumab resistance is summarized. Also explored is the potential of combination therapies for reversing trastuzumab resistance.
引用
收藏
页码：70 / 75
页数：6
相关论文
共 50 条
  • [31] Resistance to imatinib in chronic myelogenous leukemia: Mechanisms and clinical implications
    La Rosée P.
    Hochhaus A.
    Current Hematologic Malignancy Reports, 2008, 3 (2) : 72 - 79
  • [32] Concomitant radiotherapy and trastuzumab: Rational and clinical implications
    Fourati, Nejla
    Trigui, Rim
    Charfeddine, Selma
    Dhouib, Fatma
    Ben Kridis, Wala
    Abid, Leila
    Khanfir, Afef
    Mnejja, Wafa
    Daoud, Jamel
    BULLETIN DU CANCER, 2021, 108 (05) : 501 - 512
  • [33] Trastuzumab and antiestrogen therapy -: Focus on mechanisms of action and resistance
    Ocaña, A
    Cruz, JJ
    Pandiella, A
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (01): : 90 - 95
  • [34] Molecular Mechanisms of Resistance in Testicular Germ Cell Tumors - clinical Implications
    Kalayska, Katarina
    Conteduca, Vincenza
    De Giorgi, Ugo
    Mego, Michal
    CURRENT CANCER DRUG TARGETS, 2018, 18 (10) : 967 - 978
  • [35] Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer
    Yang, Wanli
    Ma, Jiaojiao
    Zhou, Wei
    Zhou, Xin
    Cao, Bo
    Zhang, Hongwei
    Zhao, Qingchuan
    Fan, Daiming
    Hong, Liu
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (12) : 1151 - 1163
  • [36] Mechanisms of Antimicrobial Resistance in Klebsiella: Advances in Detection Methods and Clinical Implications
    Li, Jian
    Shi, Yuwen
    Song, Xuanli
    Yin, Xiaoyu
    Liu, Hui
    INFECTION AND DRUG RESISTANCE, 2025, 18 : 1339 - 1354
  • [37] Molecular mechanisms and clinical implications of miRNAs in drug resistance of colorectal cancer
    Duan, Lili
    Yang, Wanli
    Feng, Weibo
    Cao, Lu
    Wang, Xiaoqian
    Niu, Liaoran
    Li, Yiding
    Zhou, Wei
    Zhang, Yujie
    Liu, Jinqiang
    Zhang, Hongwei
    Zhao, Qingchuan
    Hong, Liu
    Fan, Daiming
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [38] INSULIN-RESISTANCE AND ESSENTIAL-HYPERTENSION - MECHANISMS AND CLINICAL IMPLICATIONS
    MORRIS, AD
    CONNELL, JMC
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1994, 307 : S47 - S52
  • [39] Molecular mechanisms of glucocorticoid resistance hypersensitivity potential clinical implications - Discussion
    Bronnegard
    Chrousos
    Munck
    Kay
    Leung
    Lee
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (02) : S43 - S44
  • [40] Resistance to hormonotherapy in patients with breast cancer - molecular mechanisms and clinical implications
    Niwinska, Anna
    Litwiniuk, Maria
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2007, 11 (10): : 469 - 474
12345